Long-term recurrence rates after the removal of spinal meningiomas in relation to Simpson grades
- 467 Downloads
Simpson grade II removal (coagulation of the dural attachment after gross total removal) of spinal meningioma is considered an acceptable alternative, but increased recurrence after more than 10 years has been reported. More attention must be paid to the long-term surgical outcomes after Simpson grade II removal.
A retrospective review was performed for 20 patients (M:F = 5:15; age, 59 ± 9 years) with Simpson grade II removal (mean follow-up period, 12.9 years; range 10.0–17.5). Magnetic resonance (MR) imaging was conducted in 17 patients at 88 ± 52 months (range 12–157). During the same period, Simpson grade I removal (removal of the dural origin) was performed in 21 patients (follow-up, 89 ± 87 months; range 9–316). Radiological recurrence was defined as a visible tumor on a follow-up MR image, and clinical tumor recurrence was defined as the recurrence of symptoms.
At the final follow-up, neurological symptoms had improved in 16/20 patients and remained stable in 4/20. A recurrent tumor was detected in one patient due to increased back pain at 92 months postoperative, but the symptom was stable without surgery until the last follow-up (124 months). The radiological and clinical recurrence-free survival periods were 150 ± 7 months (95 % CI 136–163) and 204 ± 6 months (95 % CI 193–215), respectively. There was no recurrence after Simpson grade I removal, whereas neurological deterioration occurred in two patients after surgery.
Simpson grade II removal may be an alternative option if the risk of complications with Simpson grade I removal is expected to be high.
KeywordsSpinal meningiomas Meningiomas Recurrence Simpson grade Surgery
Compliance with ethical standards
Disclosure and funding source
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2010-0028631). The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. This study was approved by the institutional review board of the Seoul National University Hospital Clinical Research Institute (IRB No. 1306-106-500).
- 9.Lanzafame S, Torrisi A, Barbagallo G, Emmanuele C, Alberio N, Albanese V (2000) Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Pathol Res Pract 196:483–488. doi: 10.1016/S0344-0338(00)80050-3 CrossRefPubMedGoogle Scholar
- 13.Prayson RA, Chamberlain WA, Angelov L (2010) Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma. AIMM 18:422–428. doi: 10.1097/PAI.0b013e3181dd35d2 PubMedGoogle Scholar
- 20.Lee SH, Chung CK, Kim CH, Yoon SH, Hyun SJ, Kim KJ, Kim ES, Eoh W, Kim HJ (2013) Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group. Neuro Oncol 15:921–929. doi: 10.1093/neuonc/not038 CrossRefPubMedPubMedCentralGoogle Scholar